Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Platelets|February 14, 2019
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndromeWilliam A E Parker, Rachel C Orme, Jessica Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 29, 2019
Platelet-Specific Deletion of Cyclooxygenase-1 Ameliorates Dextran Sulfate Sodium-Induced Colitis in MiceAngela Sacco, Annalisa Bruno, Annalisa Contursi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 5, 2026
Cardiovascular pharmacotherapy in year in 2025Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 9, 2025
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024Juan Tamargo, Stefan Agewall, Giuseppe Ambrosio, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 5, 2024
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on ThrombosisBruna Gigante, Juan Tamargo, Stefan Agewall, et al.
American Journal of Hematology|November 25, 2003
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivationAmos Toren, Galit Rozenfeld-Granot, Karen E Heath, et al.
European Heart Journal|October 25, 2011
Antiplatelet agents for the treatment and prevention of atherothrombosisCarlo Patrono, Felicita Andreotti, Harald Arnesen, et al.
Blood Advances|March 29, 2018
Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarctionOliver Borst, Patrick Münzer, Nada Alnaggar, et al.
European Heart Journal|April 6, 2021
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart DiseaseJurrien Ten Berg, Dirk Sibbing, Bianca Rocca, et al.
European Heart Journal|July 13, 2023
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and HaemostasisBruna Gigante, Jerrold H Levy, Eric van Gorp, et al.
Pageof 18